Pulmonary Vascular Resistance Abnormality clinical trials at UCSF
1 research study open to eligible people
Pulmonary vascular resistance abnormality is when blood has difficulty flowing through lung vessels. UCSF is researching the heart's role in lung blood pressure problems. The trials aim to collect data from patients to examine heart-lung interactions.
PV Loop and Pulmonary Hypertension
open to eligible people ages 1-21
The right ventricular (RV) systolic function is a key determinant of outcome in patients with pulmonary hypertension and elevated pulmonary vascular resistance. As the pulmonary artery pressure and vascular resistance increase (i.e. RV afterload) in …
San Francisco, California and other locations
Our lead scientists for Pulmonary Vascular Resistance Abnormality research studies include Hythem Nawaytou, MD.
Last updated: